XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Noncontrolling Interest
Beginning Balance at Dec. 31, 2021 $ 604,102 $ 14 $ 1,324,006 $ (1,137) $ (718,891) $ 110
Beginning Balance, Shares at Dec. 31, 2021   141,393,865        
Issuance of common stock for cash upon exercise of stock options 2,734   2,734      
Issuance of common stock for cash upon exercise of stock options, Shares   648,208        
Vesting of restricted stock units   141,185        
Share-based compensation expense 12,861   12,861      
Other comprehensive Income (loss) (3,646)     (3,646)    
Net loss (62,796)       (62,736) (60)
Ending Balance at Mar. 31, 2022 553,255 $ 14 1,339,601 (4,783) (781,627) 50
Ending Balance, Shares at Mar. 31, 2022   142,183,258        
Beginning Balance at Dec. 31, 2022 464,098 $ 14 1,387,349 (4,116) (919,082) (67)
Beginning Balance, Shares at Dec. 31, 2022   143,105,002        
Issuance of common stock for cash upon exercise of stock options $ 672   672      
Issuance of common stock for cash upon exercise of stock options, Shares 145,758 145,758        
Vesting of restricted stock units   1,029,209        
Share-based compensation expense $ 14,671   14,671      
Other comprehensive Income (loss) 2,211     2,211    
Net loss (57,700)       (57,699) (1)
Ending Balance at Mar. 31, 2023 $ 423,952 $ 14 $ 1,402,692 $ (1,905) $ (976,781) $ (68)
Ending Balance, Shares at Mar. 31, 2023   144,279,969